Biomarkers World Europe 2012

More information on Biomarkers World Europe

Covering the strategic use of biomarkers in drug discovery and development

Biomarker professionals will gather together to answer the all important question- how can we get biomarkers to add value? How do you develop new medicines which demonstrate real value through predictable outcomes in targeted patient groups?

The event is a two day strategic conference tackling these questions and providing participants with a thorough review of the use of biomarkers, their effectiveness and their potential to transform R & D.

New for 2012 – Pharmaceutical and Biotech registration reduced by 50%

Come to Biomarkers World Europe and learn:
 
-How to support target identification and eliminate dead-end candidates
-How to understand the range of biomarker candidates
-How to create sophisticated animal models of human disease to develop biomarkers for proof-of pharmacology
-How to facilitate clinical trial stratification and employ early surrogate end points of efficacy
-How to define the correlation between biomarker and disease/therapeutic intervention
-How to develop fit-for-purpose biomarker assays
-How to show the clinical utility of biomarkers to improve diagnosis and make informed decision making

World class CRO or technology providers attend:

-To showcase their services to their target audience
-To meet senior biomarker professionals
-To position their brand as a leader in the pharma & biotech market
-To generate leads and new business